|
|
|
|
|
| First Name: | Giovanni | | Last Name: | Frisoni | | Title: | Dr. | | Advanced Degrees: | MD | | Affiliation: | IRCCS Fatebenefratelli | Country/Territory: | Italy | | Email Address: |  |
Disclosure:
(view policy)
|
Member reports no financial or other potential conflicts of interest. [Last Modified: 29 December 2007]
|
|
|
View all comments by Giovanni Frisoni
|
Aging Process, Tauopathies, Alzheimer Disease
|
Clinical neurologist, born in 1961, at age 30 has been among the original founders of the Italian Centre for Alzheimer's Disease at IRCCS Fatebenefratelli Hospital in Brescia where he has since been attending both clinical and scientific duties. In the past 15 years his scientific interests have encompassed the clinical neuroimaging of Alzheimer’s and other cognitive disorders. He has over 200 scientific papers listed in PubMed, about half of which as a first or last author and is member of the Editorial Board of The Lancet Neurology and other peer-reviewed journals. He has been recently in charge of the FP6 EC funded project "European NeuroImaging Repository" and the Alzheimer's Association funded "Pilot European ADNI".
At the IRCCS Fatebenefratelli he is currently Deputy Scientific Director, head of the Psychogeriatric Ward, and head of the LENITEM – Laboratory of Epidemiology Neuroimaging & Telemedicine.
|
1: Frisoni GB, Galluzzi S, Pantoni L, Filippi M. The effect of white matter lesions on cognition in the elderly--small but detectable. Nat Clin Pract Neurol. 2007 Nov;3(11):620-7.
2: Frisoni GB, Pievani M, Testa C, Sabattoli F, Bresciani L, Bonetti M, Beltramello A, Hayashi KM, Toga AW, Thompson PM. The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain. 2007 Mar;130(Pt 3):720-30. Epub 2007 Feb 9.
3: DeCarli C, Frisoni GB, Clark CM, Harvey D, Grundman M, Petersen RC, Thal LJ, Jin S, Jack CR Jr, Scheltens P; Alzheimer's Disease Cooperative Study Group. Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch Neurol. 2007 Jan;64(1):108-15.
4: Frisoni GB. Dementia: important advances in research in 2006. Lancet Neurol. 2007 Jan;6(1):4-5.
5: Whitehouse P, Frisoni GB, Post S. Breaking the diagnosis of dementia. Lancet Neurol. 2004 Feb;3(2):124-8.
6: Frisoni GB, Scheltens P, Galluzzi S, Nobili FM, Fox NC, Robert PH, Soininen H, Wahlund LO, Waldemar G, Salmon E. Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC. J Neurol Neurosurg Psychiatry. 2003 Oct;74(10):1371-81.
7: Ashburner J, Csernansky JG, Davatzikos C, Fox NC, Frisoni GB, Thompson PM. Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol. 2003 Feb;2(2):79-88.
8: Frisoni GB, Geroldi C, Beltramello A, Bianchetti A, Binetti G, Bordiga G, DeCarli C, Laakso MP, Soininen H, Testa C, Zanetti O, Trabucchi M. Radial width of the temporal horn: a sensitive measure in Alzheimer disease. AJNR Am J Neuroradiol. 2002 Jan;23(1):35-47.
9: Frisoni GB. Treatment of Alzheimer's disease with acetylcholinesterase inhibitors: bridging the gap between evidence and practice. J Neurol. 2001 Jul;248(7):551-7.
10: Frisoni GB, Fratiglioni L, Fastbom J, Viitanen M, Winblad B. Mortality in nondemented subjects with cognitive impairment: the influence of health-related factors. Am J Epidemiol. 1999 Nov 15;150(10):1031-44.
|
Early diagnosis
Atiologic therapy |
|
|
|
|
|
|
Home
